Search for Clinical Trial Results
Biliary Tract Cancer - 165 Studies Found
Status | Study |
Completed |
Study Name: Salvage mFOLFOX in BTC After Failure of Gemcitabine Condition: Unresectable Biliary Tract Cancer Date: 2010-05-05 Interventions: Drug: 5-fluorouracil, leucovorin, oxaliplatin D1 Oxaliplatin 85mg/m2 D1, 2 LV 30mg/m2 IV push D1, 2 5-FU |
Completed |
Study Name: Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer Condition: Biliary Tract Cancer Date: 2009-01-29 Interventions: Drug: Irinotecan and Gemcitabine |
Not yet recruiting |
Study Name: FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study Condition: Biliary Tract Cancer Date: 2017-04-07 Interventions:
|
Not yet recruiting |
Study Name: Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study Condition: Biliary Tract Cancer Date: 2017-04-07 Interventions:
|
Completed |
Study Name: A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer Condition:
|
Terminated |
Study Name: Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer Condition: Biliary Tract Cancer Date: 2010-07-27 Interventions: Drug: Gemcitabine TS-1 Gemcitabine (1,000mg/m2) will be administered on days 1 and 8 at every 3 weeks TS |
Recruiting |
Study Name: Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC Condition: Biliary Tract Cancer Date: 2016-12-08 Interventions:
|
Recruiting |
Study Name: Ramucirumab for Advanced Pre-treated Biliary Cancers Condition: Biliary Cancer Date: 2015-08-05 Interventions: Drug: Ramucirumab 8 mg/kg by vein on Day 1 of each 14 day cycle. |
Recruiting |
Study Name: A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer Condition:
|
Recruiting |
Study Name: Pembrolizumab and GM-CSF in Biliary Cancer Condition: Biliary Cancer Date: 2016-03-04 Interventions:
|